Humana (HUM) Competitors $227.78 -2.89 (-1.25%) As of 12:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HUM vs. CI, CNC, ELV, MOH, UNH, SEM, JYNT, AEMD, MDT, and BMYShould you be buying Humana stock or one of its competitors? The main competitors of Humana include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), UnitedHealth Group (UNH), Select Medical (SEM), Joint (JYNT), Aethlon Medical (AEMD), Medtronic (MDT), and Bristol Myers Squibb (BMY). These companies are all part of the "medical" sector. Humana vs. Its Competitors Cigna Group Centene Elevance Health Molina Healthcare UnitedHealth Group Select Medical Joint Aethlon Medical Medtronic Bristol Myers Squibb Cigna Group (NYSE:CI) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk. Which has stronger valuation and earnings, CI or HUM? Cigna Group has higher revenue and earnings than Humana. Humana is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCigna Group$247.12B0.33$3.43B$18.0616.68Humana$117.76B0.23$1.21B$14.1416.06 Which has more risk & volatility, CI or HUM? Cigna Group has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Is CI or HUM a better dividend stock? Cigna Group pays an annual dividend of $6.04 per share and has a dividend yield of 2.0%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.6%. Cigna Group pays out 33.4% of its earnings in the form of a dividend. Humana pays out 25.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Do insiders and institutionals have more ownership in CI or HUM? 87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.7% of Cigna Group shares are owned by company insiders. Comparatively, 0.4% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer CI or HUM? In the previous week, Cigna Group had 9 more articles in the media than Humana. MarketBeat recorded 31 mentions for Cigna Group and 22 mentions for Humana. Cigna Group's average media sentiment score of 1.25 beat Humana's score of 0.68 indicating that Cigna Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cigna Group 27 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Humana 10 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer CI or HUM? Cigna Group currently has a consensus target price of $380.39, suggesting a potential upside of 26.24%. Humana has a consensus target price of $280.76, suggesting a potential upside of 23.62%. Given Cigna Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cigna Group is more favorable than Humana.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cigna Group 0 Sell rating(s) 2 Hold rating(s) 16 Buy rating(s) 2 Strong Buy rating(s) 3.00Humana 0 Sell rating(s) 16 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.30 Is CI or HUM more profitable? Cigna Group has a net margin of 1.97% compared to Humana's net margin of 1.42%. Cigna Group's return on equity of 18.63% beat Humana's return on equity.Company Net Margins Return on Equity Return on Assets Cigna Group1.97% 18.63% 4.97% Humana 1.42%14.47%5.03% SummaryCigna Group beats Humana on 16 of the 19 factors compared between the two stocks. Get Humana News Delivered to You Automatically Sign up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HUM vs. The Competition Export to ExcelMetricHumanaMED IndustryMedical SectorNYSE ExchangeMarket Cap$27.44B$40.91B$5.54B$20.64BDividend Yield1.53%101.64%5.06%3.71%P/E Ratio16.088.9228.2927.82Price / Sales0.230.76374.5355.14Price / Cash9.668.9124.7217.94Price / Book1.662.608.254.59Net Income$1.21B$2.64B$3.19B$989.58M7 Day Performance-4.17%-3.27%5.46%0.98%1 Month Performance-3.30%-13.58%9.42%5.30%1 Year Performance-40.58%-35.21%30.15%10.40% Humana Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HUMHumana4.529 of 5 stars$227.78-1.3%$280.76+23.3%-39.7%$27.47B$117.76B16.1065,680Analyst DowngradeCICigna Group4.9985 of 5 stars$312.06-2.4%$380.39+21.9%-9.6%$83.36B$247.12B17.2873,500Positive NewsCNCCentene4.9789 of 5 stars$33.20-0.3%$68.87+107.5%-53.7%$16.52B$163.07B4.9560,500Trending NewsAnalyst ForecastHigh Trading VolumeELVElevance Health4.9608 of 5 stars$346.59-0.4%$498.87+43.9%-36.5%$78.30B$177.01B13.52104,200Upcoming EarningsAnalyst ForecastMOHMolina Healthcare4.9879 of 5 stars$233.33-2.6%$364.21+56.1%-24.7%$12.65B$40.65B11.2718,000Analyst ForecastUNHUnitedHealth Group4.997 of 5 stars$303.39-1.7%$415.57+37.0%-40.6%$275.22B$400.28B12.70400,000Positive NewsUpcoming EarningsSEMSelect Medical5 of 5 stars$14.93-1.4%$26.00+74.2%-60.7%$1.92B$5.19B11.1444,100JYNTJoint3.3351 of 5 stars$11.87+1.5%$15.50+30.6%-15.8%$181.53M$51.90M-20.46320AEMDAethlon Medical1.8876 of 5 stars$1.16-6.9%$56.00+4,748.5%-65.3%$2.99M$570K-0.0910MDTMedtronic4.5954 of 5 stars$87.52-1.0%$97.87+11.8%+15.5%$112.25B$33.54B24.1895,000Positive NewsAnalyst ForecastBMYBristol Myers Squibb4.884 of 5 stars$46.51-0.9%$58.00+24.7%+15.9%$94.64B$48.30B17.4234,100Analyst Revision Related Companies and Tools Related Companies CI Alternatives CNC Alternatives ELV Alternatives MOH Alternatives UNH Alternatives SEM Alternatives JYNT Alternatives AEMD Alternatives MDT Alternatives BMY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HUM) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humana Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.